Skip to main content

Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant

The Original Article was published on 15 September 2016

Correction to: J Hematol Oncol (2016) 9:87

https://doi.org/10.1186/s13045-016-0319-5

The original article [1] contains two errors in the MRD Testing sub-section of the Methods:

  1. 1)

    The description, “…by four-color flow cytometry (FCM)” was incorrect. The correct description should be “…by eight-color flow cytometry (FCM)”.

  2. 2)

    The description, “LAIPs were detected by four-color FCM” was incorrect. The correct description should be “LAIPs were detected by eight-color FCM”.

Reference

  1. Yan C-H, et al. Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant. J Hematol Oncol. 2016;9:87. https://doi.org/10.1186/s13045-016-0319-5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-Jun Huang.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, CH., Wang, Y., Wang, JZ. et al. Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant. J Hematol Oncol 12, 24 (2019). https://doi.org/10.1186/s13045-019-0715-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13045-019-0715-8